Parents 	Parents 	 NNS	O
'  	'  	 ''	O
and  	and  	 CC	O
Adolescents 	Adolescents 	 NNP	O
'  	'  	 POS	O
Preferences  	Preferences  	 NNPS	O
for  	for  	 IN	O
Intensified  	Intensified  	 NNP	O
or  	or  	 CC	O
Reduced  	Reduced  	 NNP	B-NP
Treatment  	Treatment  	 NNP	I-NP
in  	in  	 IN	O
Randomized  	Randomized  	 NNP	O
Lymphoblastic  	Lymphoblastic  	 NNP	B-NP
Leukemia  	Leukemia  	 NNP	I-NP
Trials  	Trials  	 NNP	I-NP
When  	When  	 WRB	O
offered  	offered  	 VBN	B-NP
participation  	participation  	 NN	I-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
trials 	trials 	 NNS	I-NP
,  	,  	 ,	O
families  	families  	 NNS	O
of  	of  	 IN	O
children  	children  	 NNS	O
with  	with  	 IN	O
cancer  	cancer  	 NN	O
face  	face  	 VBP	O
a  	a  	 DT	O
delicate  	delicate  	 JJ	O
balance  	balance  	 NN	O
between  	between  	 IN	O
cure  	cure  	 NN	O
and  	and  	 CC	O
toxicity 	toxicity 	 NN	O
.  	.  	 .	O
Since  	Since  	 IN	O
parents  	parents  	 NNS	O
and  	and  	 CC	O
children  	children  	 NNS	O
may  	may  	 MD	O
perceive  	perceive  	 VB	O
this  	this  	 DT	O
balance  	balance  	 NN	O
differently 	differently 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
paper  	paper  	 NN	O
explores  	explores  	 NN	O
whether  	whether  	 IN	O
adolescent  	adolescent  	 JJ	O
patients  	patients  	 NNS	O
have  	have  	 VBP	O
different  	different  	 JJ	O
enrollment  	enrollment  	 NN	B-NP
patterns  	patterns  	 NNS	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
younger  	younger  	 JJR	O
children  	children  	 NNS	O
in  	in  	 IN	O
trials  	trials  	 NNS	O
with  	with  	 IN	O
different  	different  	 JJ	O
toxicity  	toxicity  	 NN	B-NP
profiles 	profiles 	 NNS	I-NP
.  	.  	 .	O
Age-dependent  	Age-dependent  	 JJ	B-NP
participation  	participation  	 NN	I-NP
rates  	rates  	 NNS	I-NP
in  	in  	 IN	O
three  	three  	 CD	O
consecutive 	consecutive 	 JJ	O
,  	,  	 ,	O
randomized  	randomized  	 JJ	B-NP
childhood  	childhood  	 NN	I-NP
leukemia  	leukemia  	 NN	I-NP
trials  	trials  	 NNS	I-NP
conducted  	conducted  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Nordic  	Nordic  	 NNP	B-NP
Society  	Society  	 NNP	I-NP
of  	of  	 IN	I-NP
Paediatric  	Paediatric  	 NNP	I-NP
Haematology  	Haematology  	 NNP	I-NP
and  	and  	 CC	O
Oncology  	Oncology  	 NNP	B-NP
were  	were  	 VBD	O
evaluated 	evaluated 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
ALL2000  	ALL2000  	 FW	O
dexamethasone 	dexamethasone 	 FW	B-NP
/ 	/ 	 FW	I-NP
vincristine  	vincristine  	 FW	I-NP
( 	( 	 -LRB-	O
Dx 	Dx 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
VCR 	VCR 	 NNP	I-NP
)  	)  	 -RRB-	O
trial  	trial  	 NN	O
tested  	tested  	 VBN	B-NP
treatment  	treatment  	 NN	I-NP
intensifications  	intensifications  	 NN	I-NP
to  	to  	 TO	O
improve  	improve  	 VB	O
cure 	cure 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
back-to-back  	back-to-back  	 JJ	B-NP
ALL2008  	ALL2008  	 NNP	O
6-mercaptopurine  	6-mercaptopurine  	 NNP	B-NP
( 	( 	 -LRB-	O
6MP 	6MP 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
ALL2008  	ALL2008  	 NNP	O
PEG-asparaginase  	PEG-asparaginase  	 NNP	B-NP
( 	( 	 -LRB-	O
ASP 	ASP 	 NNP	B-NP
)  	)  	 -RRB-	O
trials  	trials  	 NNS	O
tested  	tested  	 VBN	B-NP
treatment  	treatment  	 NN	I-NP
intensifications  	intensifications  	 NNS	I-NP
( 	( 	 -LRB-	O
6MP 	6MP 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
toxicity  	toxicity  	 JJ	B-NP
reduction  	reduction  	 NN	I-NP
without  	without  	 IN	O
compromising  	compromising  	 JJ	O
survival  	survival  	 NN	O
( 	( 	 -LRB-	O
ASP 	ASP 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Patient  	Patient  	 JJ	B-NP
randomization  	randomization  	 NN	I-NP
and  	and  	 CC	O
toxicity  	toxicity  	 JJ	O
data  	data  	 NNS	O
were  	were  	 VBD	O
prospectively  	prospectively  	 RB	O
registered  	registered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
treating  	treating  	 JJ	O
physicians 	physicians 	 NNS	O
.  	.  	 .	O
Parents  	Parents  	 NNS	O
of  	of  	 IN	O
young  	young  	 JJ	O
children  	children  	 NNS	O
favored  	favored  	 VBD	B-NP
treatment  	treatment  	 NN	I-NP
intensifications  	intensifications  	 NNS	I-NP
( 	( 	 -LRB-	O
Dx 	Dx 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
VCR 	VCR 	 NNP	I-NP
:  	:  	 :	O
12 	12 	 CD	O
%  	%  	 NN	O
refusal 	refusal 	 NN	O
;  	;  	 :	O
6MP 	6MP 	 CD	B-NP
:  	:  	 :	O
14 	14 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
ASP 	ASP 	 NNP	B-NP
:  	:  	 :	O
21 	21 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
whereas  	whereas  	 IN	O
parents  	parents  	 NNS	O
of  	of  	 IN	O
adolescents  	adolescents  	 JJ	O
favored  	favored  	 JJ	O
treatment  	treatment  	 NN	B-NP
reductions  	reductions  	 NNS	I-NP
( 	( 	 -LRB-	O
Dx 	Dx 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
VCR 	VCR 	 NNP	I-NP
:  	:  	 :	O
52 	52 	 CD	O
%  	%  	 NN	O
refusal 	refusal 	 NN	O
;  	;  	 :	O
6MP 	6MP 	 CD	B-NP
:  	:  	 :	O
30 	30 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
ASP 	ASP 	 NNP	B-NP
:  	:  	 :	O
8 	8 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Adolescents  	Adolescents  	 NNP	O
were  	were  	 VBD	O
more  	more  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
refuse  	refuse  	 VB	O
intensification  	intensification  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
than  	than  	 IN	O
young  	young  	 JJ	O
children  	children  	 NNS	O
( 	( 	 -LRB-	O
adjusted  	adjusted  	 VBN	O
ORs  	ORs  	 JJ	O
6.3 	6.3 	 CD	O
;  	;  	 :	O
P  	P  	 NN	O
< 	< 	 SYM	O
0.01  	0.01  	 CD	O
[ 	[ 	 -LRB-	O
Dx 	Dx 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
VCR 	VCR 	 NNP	I-NP
]  	]  	 -RRB-	O
and  	and  	 CC	O
2.1 	2.1 	 CD	O
;  	;  	 :	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.04  	0.04  	 FW	O
[ 	[ 	 -LRB-	O
6MP 	6MP 	 NNP	B-NP
] 	] 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Adolescents  	Adolescents  	 NNP	O
were  	were  	 VBD	O
less  	less  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
refuse  	refuse  	 VB	O
the  	the  	 DT	O
ASP  	ASP  	 NNP	B-NP
trial 	trial 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
varying  	varying  	 VBG	B-NP
effect  	effect  	 NN	I-NP
size  	size  	 NN	I-NP
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
preceding  	preceding  	 JJ	O
consolidation  	consolidation  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
( 	( 	 -LRB-	O
adjusted  	adjusted  	 VBN	O
OR  	OR  	 NNP	O
for  	for  	 IN	O
median  	median  	 JJ	B-NP
consolidation  	consolidation  	 NN	I-NP
length  	length  	 NN	I-NP
0.15 	0.15 	 CD	O
;  	;  	 :	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.01 	0.01 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Younger  	Younger  	 JJR	O
children  	children  	 NNS	O
participated  	participated  	 VBD	O
more  	more  	 RBR	O
frequently  	frequently  	 RB	O
in  	in  	 IN	O
only  	only  	 JJ	O
6MP  	6MP  	 NN	B-NP
than  	than  	 IN	O
in  	in  	 IN	O
only  	only  	 JJ	O
ASP  	ASP  	 NNP	B-NP
( 	( 	 -LRB-	O
14 	14 	 CD	O
%  	%  	 NN	O
vs.  	vs.  	 IN	O
5 	5 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
adolescents  	adolescents  	 FW	O
vice  	vice  	 FW	B-NP
versa  	versa  	 FW	I-NP
( 	( 	 -LRB-	O
2 	2 	 CD	O
%  	%  	 NN	O
vs.  	vs.  	 IN	O
17 	17 	 CD	O
% 	% 	 NN	O
;  	;  	 :	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Parents 	Parents 	 NNS	O
'  	'  	 ''	O
and  	and  	 CC	O
adolescents 	adolescents 	 NN	O
'  	'  	 POS	O
divergent  	divergent  	 JJ	O
inclinations  	inclinations  	 NN	B-NP
toward  	toward  	 IN	O
intensified  	intensified  	 NN	O
or  	or  	 CC	O
reduced  	reduced  	 JJ	O
therapy  	therapy  	 NN	O
emphasize  	emphasize  	 VBD	O
the  	the  	 DT	O
necessity  	necessity  	 NN	O
of  	of  	 IN	O
actively  	actively  	 RB	O
involving  	involving  	 VBG	B-NP
adolescents  	adolescents  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
informed  	informed  	 JJ	O
consent  	consent  	 NN	B-NP
process 	process 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
should  	should  	 MD	O
also  	also  	 RB	O
address  	address  	 VB	O
motives  	motives  	 NNS	O
for  	for  	 IN	O
trial  	trial  	 NN	B-NP
participation 	participation 	 NN	I-NP
.  	.  	 .	O
